| Name | Title | Contact Details |
|---|
AAAT.L.C Healthcare is a Encino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
One of the fastest growing companies in America, Shields Health Solutions partners with hospital leaders on every aspect of specialty pharmacy creation and growth. The company provides the fastest, lowest risk model for Hospital leaders to create and grow a hospital-owned specialty pharmacy business, whether starting from scratch or adding specialty capabilities to a hospital`s existing pharmacy programs.
Generation after generation, families have depended upon Silver Cross Hospital to care for their loved ones. The commitment goes back to Thanksgiving Day in 1895 when the Will County Union of King`s Daughters and Sons opened the doors of a 33-bed hospital in Joliet named after their emblem the Maltese cross. Their promise was to provide quality healthcare with compassion for the citizens of Will County and surrounding communities. Today, more than a century later, Silver Cross Hospital remains true to that original promise. As the needs of the community grew, so did Silver Cross—in size and stature. Services rapidly expanded, evolved and increased in complexity. The medical staff advanced superior healthcare and attracted new expertise including specialists with Ann & Robert H. Lurie Children`s Hospital of Chicago, The Rehabilitation Institute of Chicago (RIC), University of Chicago Medicine Comprehensive Cancer Center, Northwestern Medicine for neurosciences and stroke care, and the Midwest Institute for Robotic Surgery. Silver Cross performs more robotic-assisted procedures than any other facility in the Chicago area. Surgeons from around the world come train with us. National prominence was achieved when Silver Cross- an independent healthcare provider, was first recognized as one of the nation`s 100 Top Hospitals in 2004—an accomplishment that has been repeated for seven years. And year after year, Silver Cross has been acknowledged as one of American`s Friendliest Hospitals because we treat patients the way they should be treated and for our dedication to patient safety with an “A” Hospital Safety Score from the Leapfrog Group. The mission of providing quality healthcare continues today with a remarkable 296-bed replacement hospital, which opened in 2012. All patient rooms are private—accommodating today`s medical technology and ultimately reducing unnecessary transfers and the risk of infection and injury. The hospital`s unique design creates efficiencies between departments and promotes an environment that helps patients heal faster. Our 158-acre New Lenox campus includes three medical/office buildings, University of Chicago Medicine Comprehensive Cancer Center, and an ambulatory care center opening in fall 2017. The hospital also has plans to build a 100-bed Behavioral Health Hospital to open in 2019. Over the years, Silver Cross has developed an extensive ambulatory network throughout the region that includes five satellite facilities with the independent services of many physicians and an array of outpatient services such as diagnostic imaging and rehabilitation. Silver Cross also operates a 27/7 freestanding Emergency Care Center in Homer Glen and an Urgent Care center in Joliet.
Burbank HealthCare Foundation is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.